The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
Introduction to the REBECCA Case Report Form
As of 2022, breast cancer is the most common form of cancer among women worldwide. Following their primary cancer treatment, women are facing significant challenges in their lives. These include physical symptoms, such as pain or fatigue, as well as emotional symptoms, including fear of cancer re…
Garmin recognizes the value of REBECCA’s novel indicators
On 30 September, Dr Konstantinos Kyritsis from the Multimedia Understanding Group (MUG), Department of Electrical and Computer Engineering at the Aristotle University of Thessaloniki presented the REBECCA project at the Garmin Health Summit ‘22. In his presentation, Dr Konstantinos Kyritsis focus…
INCLIVA presents the REBECCA project at a meeting with patients’ associations
Last week of September, the INCLIVA Biomedical Research Institute organized a meeting with patients’ associations in collaboration with the Breast Cancer Unit of the Hospital Clinic of Valencia. The objective of the meeting was to disseminate the latest advances in breast cancer research, present…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.